Back to companies
Alaunos Therapeutics, Inc.
TCRTUSNASDAQPharmaceuticals & HealthcareAlaunos Therapeutics, Inc.
Revenue
$5,000
YoY -50.0%
Operating income
-$4.2mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API